title: Treating heparin-induced thrombocytopenia. The unconventional way!
authors.affiliation: Department of Medicine, King Fahad Armed Forces Hospital, PO Box 9862, Jeddah 21159, Kingdom of Saudi Arabia. razeq@yahoo.com
authors.forename: Hikmat N
authors.initials: HN
authors.lastname: Abdel-Razeq
authors.forename: Ali A
authors.initials: AA
authors.lastname: Bajouda
authors.forename: Manar M
authors.initials: MM
authors.lastname: Khalil
authors.forename: Abdullah K
authors.initials: AK
authors.lastname: Ashmeg
mesh_terms: D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005500:Follow-Up Studies; D006493:Heparin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy; D010956:Plasmapheresis / Q000379:methods*; D018570:Risk Assessment; D012529:Saudi Arabia; D012720:Severity of Illness Index; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D006493:Heparin